Skip to main content
CG MedTech Co.,Ltd. logo

CG MedTech Co.,Ltd. — Investor Relations & Filings

Ticker · 056090 ISIN · KR7056090004 KO Manufacturing
Open in API
Filings indexed 430 across all filing types
Latest filing 2024-06-10 Regulatory Filings
Country KR South Korea
Listing KO 056090

About CG MedTech Co.,Ltd.

https://cgmedt.com/

CG MedTech Co., Ltd. is a medical technology company that designs, manufactures, and distributes orthopedic medical devices and surgical implants. The company's product portfolio encompasses solutions for spine, trauma, pain management, sports medicine, and biologics. Key offerings include spinal fixation devices, bioabsorbable alloy implants, and systems for fracture treatment. CG MedTech focuses on regenerative medicine and the development of innovative technologies, such as patient-specific 3D printed implants, to enhance tissue regeneration and improve patient outcomes.

Recent filings

Filing Released Lang Actions
소속부변경
Regulatory Filings Classification · 100% confidence The document is a short regulatory announcement regarding a change in the company's market classification (소속부변경) for Innosys. It does not contain full financial statements or detailed reports, but rather serves as a formal notification of a regulatory status change. As it does not fit into specific categories like M&A, dividends, or director dealings, it falls under the general regulatory filing category.
2024-06-10 Korean
분기보고서 (2024.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company '이노시스(주)' covering the period from 2024.01.01 to 2024.03.31. It contains detailed corporate information, management history, capital structure, and governance details, which are standard components of a comprehensive quarterly financial report filed with the Financial Supervisory Service (FSS) in South Korea. It is not an announcement or a summary, but the full report itself. Q1 2024
2024-05-16 Korean
기타시장안내 (개선계획 이행내역서 제출)
Legal Proceedings Report Classification · 100% confidence The document is a short regulatory announcement from the Korea Exchange regarding the submission of an improvement plan implementation report by the company 'Innosys'. It outlines the timeline for the exchange's review process (Corporate Review Committee) and potential delisting or trading resumption outcomes. Since it is a regulatory notice regarding listing status and does not contain the full financial report itself, it falls under the general regulatory filing category.
2024-05-13 Korean
기타시장안내 (개선기간 종료에 따른 상장폐지여부 결정 안내)
Delisting Announcement Classification · 100% confidence The document is a formal notice from the Korea Exchange regarding the status of a company's listing (Innosys). It details the expiration of an improvement period and the subsequent process for determining potential delisting. This falls under regulatory announcements regarding listing status, which is best categorized as a Regulatory Filing (RNS) as it does not fit into specific categories like 'Delisting Announcement' (which usually refers to the final act of removal) or 'Legal Proceedings'.
2024-04-18 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official report of the results of a General Meeting of Shareholders (정기주주총회결과), detailing the approval of financial statements, election of auditors, and remuneration limits. This falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2024-03-29 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal regulatory filing titled 'Audit Report Submission' (감사보고서 제출) submitted to the Korea Exchange (KRX). It contains detailed financial tables including consolidated and separate financial statements, audit opinions, and financial ratios for the current and previous fiscal years. While it provides financial data, it is a standard regulatory disclosure form used in the Korean market to announce the completion and submission of the audit report, rather than the full, multi-page audited financial statement document itself. Therefore, it is classified as a Regulatory Filing. FY 2023
2024-03-21 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.